Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1184062.RAfmcSg4MpYCmQ2CBuczZhUnw1FveZT7LnGj1Mgk_bVB8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1184062.RAfmcSg4MpYCmQ2CBuczZhUnw1FveZT7LnGj1Mgk_bVB8130_assertion type Assertion NP1184062.RAfmcSg4MpYCmQ2CBuczZhUnw1FveZT7LnGj1Mgk_bVB8130_head.
- NP1184062.RAfmcSg4MpYCmQ2CBuczZhUnw1FveZT7LnGj1Mgk_bVB8130_assertion description "[The aim of this study was to determine the prognostic power of minimal residual disease (MRD) measured by fluorescence in situ hybridization (FISH) in CD34(+)CD38(-) cells sorted by flow cytometry at different periods during therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1184062.RAfmcSg4MpYCmQ2CBuczZhUnw1FveZT7LnGj1Mgk_bVB8130_provenance.
- NP1184062.RAfmcSg4MpYCmQ2CBuczZhUnw1FveZT7LnGj1Mgk_bVB8130_assertion evidence source_evidence_literature NP1184062.RAfmcSg4MpYCmQ2CBuczZhUnw1FveZT7LnGj1Mgk_bVB8130_provenance.
- NP1184062.RAfmcSg4MpYCmQ2CBuczZhUnw1FveZT7LnGj1Mgk_bVB8130_assertion SIO_000772 24844781 NP1184062.RAfmcSg4MpYCmQ2CBuczZhUnw1FveZT7LnGj1Mgk_bVB8130_provenance.
- NP1184062.RAfmcSg4MpYCmQ2CBuczZhUnw1FveZT7LnGj1Mgk_bVB8130_assertion wasDerivedFrom befree-2016 NP1184062.RAfmcSg4MpYCmQ2CBuczZhUnw1FveZT7LnGj1Mgk_bVB8130_provenance.
- NP1184062.RAfmcSg4MpYCmQ2CBuczZhUnw1FveZT7LnGj1Mgk_bVB8130_assertion wasGeneratedBy ECO_0000203 NP1184062.RAfmcSg4MpYCmQ2CBuczZhUnw1FveZT7LnGj1Mgk_bVB8130_provenance.